According to WuXi Biologics's latest financial reports the company has $1.19 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $1.26 B | -27.64% |
2021-12-31 | $1.74 B | 34.29% |
2020-12-31 | $1.30 B | 34.6% |
2019-12-31 | $0.96 B | 62.66% |
2018-12-31 | $0.59 B | 87.56% |
2017-12-31 | $0.31 B | 1200.24% |
2016-12-31 | $24.35 M | -0.25% |
2015-12-31 | $24.41 M | 2441.5% |
2014-12-31 | $0.96 M |